Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Indoximod Plus Immune Checkpoint Inhibitors in Advanced Melanoma
NCT02073123Phase 2Completed
- Sponsor
- Lumos Pharma, Inc.
- Start
- Jul 2014
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of indoximod in melanoma, sponsored by Lumos Pharma, Inc.. Started Jul 2014; status: completed.
02
Drugs
indoximod
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02073123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02073123.